Literature DB >> 5090133

Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types 3, IV, and V familial hyperlipoproteinemia.

C J Glueck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5090133     DOI: 10.1016/0026-0495(71)90083-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  7 in total

Review 1.  Indications for lipid-lowering drugs.

Authors:  J Davignon
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

Review 2.  Progestagens, anabolic-androgenic compounds, estrogens: effects on triglycerides and postheparin lipolytic enzymes.

Authors:  C J Glueck; D Scheel; J Fishback; P Steiner
Journal:  Lipids       Date:  1972-02       Impact factor: 1.880

Review 3.  Gonadal hormones and triglycerides.

Authors:  C J Glueck; R Fallat
Journal:  Proc R Soc Med       Date:  1974-06

4.  Study of the lipid-lowering action of choloxin and nilevar in patients with chronic renal failure.

Authors:  E N Wardle; W Schardt; P R Uldall; A Brown; D Jonfiah; A Moore; R Park; E Wood
Journal:  Postgrad Med J       Date:  1974-12       Impact factor: 2.401

5.  Augmented release of hepatic triglycerides with anabolic steroids in patients with fatty liver.

Authors:  C L Mendenhall
Journal:  Am J Dig Dis       Date:  1974-02

Review 6.  Lipid-lowering drugs. An overview of indications and optimum therapeutic use.

Authors:  D R Illingworth
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 7.  Recent developments in the toxicology of anabolic steroids.

Authors:  S Graham; M Kennedy
Journal:  Drug Saf       Date:  1990 Nov-Dec       Impact factor: 5.606

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.